← Back to Search

Smoking Cessation Program for Caregivers Who Smoke

Phase 4
Recruiting
Led By Brian Williams, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant is willing and able to use NRT
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study recruitment, approximately 6 months
Awards & highlights

Study Summary

This trial studies how a smoking cessation program affects caregivers' smoking behavior while their child is in the hospital.

Who is the study for?
This trial is for caregivers over 18 who smoke at least 5 cigarettes a day and have a child admitted to the hospital for more than 24 hours. They must be the primary caregiver, not pregnant or breastfeeding, willing to use birth control, and able to commit to the study's duration without needing an interpreter.Check my eligibility
What is being tested?
The study tests if caregivers will engage in a smoking cessation program during their child's hospital stay. It includes completing surveys, undergoing counseling sessions, and using nicotine patches and lozenges for two weeks.See study design
What are the potential side effects?
Possible side effects from nicotine replacement therapy (NRT) include skin irritation from patches, mouth issues with lozenges like soreness or hiccups, headaches, nausea, dizziness or sleep disturbances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing and able to use nicotine replacement therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study recruitment, approximately 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and study recruitment, approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of smoking intervention
Enrollment in study
NRT use
Secondary outcome measures
Change in motivation to quit smoking
Change in number of cigarettes smoked per day
Change in self-confidence in quitting smoking
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Caregivers of hospitalized childrenExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,496 Total Patients Enrolled
24 Trials studying Smoking
41,909 Patients Enrolled for Smoking
Brian Williams, MDPrincipal InvestigatorUniversity of Wisconsin, Madison

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Food and Drug Administration given their seal of approval to Caregivers of hospitalized children?

"A score of 3 was assigned to this Phase 4 trial, signifying that the safety profile for Caregivers is satisfactory as it has already been approved."

Answered by AI

Are there any vacancies available for participants in this research?

"The clinical trial, which was first announced on September 1st 2023 and last edited 19 days later, is not presently looking for patients. However, there are 187 other studies currently recruiting volunteers."

Answered by AI

What results are researchers anticipating from this clinical experiment?

"The primary metric being assessed over a 6 month recruitment period is cessation of nicotine use. Secondary objectives include gauging how often the participant leaves their child's bedside to smoke, self-reported confidence in quitting smoking (with scores ranging from 1-7), and self-reported motivation to quit smoking (also with scores graded between 1 and 7)."

Answered by AI
~33 spots leftby Oct 2024